Zacks Small Cap Research on MSN

DWTX: Positive interim results for Halneuron® Phase 2b trial in CINP; raising valuation to $15

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Positive Interim Results for Phase 2b Trial of Halneuron® in CINP On December 22, 2025, Dogwood Therapeutics, Inc. (DWTX) announced positive ...
GitHub

Diverse Genomic Embedding Benchmark

DGEB is a benchmark for evaluating biological sequence models on functional and evolutionary information. DGEB is designed to evaluate model embeddings using: Diverse sequences accross the tree of ...